展望第三季度，管理层预计营收将达7200万至7600万美元，同比增幅70%至79%。CEO黄汪表示，本季度是上升周期的 开端，丰富的创新管线将支撑下半年及未来的持续增长，巩固Amazfit在性能可穿戴领域的创新领导地位。 华米科技(ZEPP.US)美股盘初快速拉升涨超48%，高见19.26美元创2022年3月以来新高，近一个月累计升幅更是超 550%。 财报显示，核心品牌Amazfit成为增长引擎，其Bip 6、Active 2系列持续热销，高端机型T-Rex 3表现强劲，6月新推出的 Balance 2智能手表和Helio手环亦贡献显著。盈利层面，GAAP净亏损770万美元，经调整净亏损616万美元，较去年同期 分别收窄28.6%和30.2%，毛利率稳定在36.2%。 消息上，华米科技公布截止2025年6月30日止第二季度业绩显示，当期营收同比大幅增长46.2%，不仅超出此前业绩指引 上限，更标志着自2021年以来首次实现整体营收增长。 ...

格隆汇8月4日｜华米科技(ZEPP.US)公布截止2025年6月30日止第二季度业绩显示，当期营收同比大幅增 长46.2%，不仅超出此前业绩指引上限，更标志着自2021年以来首次实现整体营收增长。 财务健康度持续改善，运营费用环比下降，期末现金储备达9530万美元。公司战略性增加库存应对新品 上市及关税风险，同时推进股票回购计划，彰显长期信心。 展望第三季度，管理层预计营收将达7200万至7600万美元，同比增幅70%至79%。CEO黄汪表示，本季 度是上升周期的开端，丰富的创新管线将支撑下半年及未来的持续增长，巩固Amazfit在性能可穿戴领 域的创新领导地位。 财报显示，核心品牌Amazfit成为增长引擎，其Bip 6、Active 2系列持续热销，高端机型T-Rex 3表现强 劲，6月新推出的Balance 2智能手表和Helio手环亦贡献显著。盈利层面，GAAP净亏损770万美元，经调 整净亏损616万美元，较去年同期分别收窄28.6%和30.2%，毛利率稳定在36.2%。 战略转型成效显著，Zepp聚焦Amazfit品牌生态系统建设，推出搭载AI功能的Zepp OS 5.0系统，深化与 Strava ...

"This quarter is just the beginning of our upward trajectory. With a robust pipeline of innovations, we're well- equipped to build on this momentum, driving sustained growth and value through the second half of 2025 and beyond," Mr. Huang concluded. Mr. Leon Deng, Zepp's Chief Financial Officer, added, "In the second quarter of 2025, we exceeded the high end of our revenue guidance, driven by strong demand for our Amazfit Bip 6, Active 2, and T-Rex 3 models. The June launches of the Helio Strap and Balance ...

Core Insights - Zepp Health Corporation reported a 10% year-over-year growth in Amazfit revenue for Q1 2025, despite a challenging macroeconomic environment [1][3][6] - The company successfully launched new smartwatch models, Amazfit Active 2 and Bip 6, which have received positive market reception and are expected to drive further sales growth [1][2][6] - The management anticipates a year-over-year revenue increase for Q2 2025, projecting net revenues between US$50 million and US$55 million, representing a growth of approximately 23% to 35% compared to Q2 2024 [3][21] Financial Performance - Total revenue for Q1 2025 was US$39 million, with Amazfit-branded products growing by 10.2% year-over-year [3][6] - Gross margin improved to 37.3%, up from 36.8% in the same period last year, despite facing additional tariffs [3][7] - The net loss for Q1 2025 was US$19.7 million, compared to a net loss of US$14.8 million in Q1 2024 [15][33] Operating Expenses - Total operating expenses for Q1 2025 were US$32.7 million, a 6.9% increase year-over-year, driven by higher selling and marketing expenses [12][9] - Research and development expenses decreased by 7.8% year-over-year to US$12.4 million, reflecting a focus on resource efficiency [8] - Selling and marketing expenses rose by 28.5% year-over-year to US$13.8 million, primarily due to investments in digital campaigns and product launches [9][12] Cash and Debt Management - The company had a cash balance of US$104 million as of March 31, 2025, after repaying US$11.5 million in short-term debt [3][4] - Long-term borrowings now represent about 70% of total debt, with US$67.8 million of debt retired since early 2023 [4][18] - Improved working capital management contributed to a tighter cash conversion cycle, allowing for continued investment in growth opportunities [16][18] Market Strategy and Outlook - Zepp Health is committed to leveraging open-source technologies and enhancing AI capabilities to improve product offerings and user experience [2] - The company is expanding its brand presence through partnerships with athletes and community events, aiming to strengthen user connections and broaden its market reach [2][21] - Management remains focused on optimizing the supply chain and investing in AI-driven experiences to maintain leadership in the wearable market [2][21]